October 29, 2021 10:38 AM EDT

Covid-19 roundup: Takeda preps rollout of Novavax shot for next year — report; G20 targets 70% world vaccination rate by mid-2022

Nicole DeFeudis

Editor

Josh Sullivan

A couple days after Novavax filed for authorization of its Covid-19 vaccine in the UK, the company is reportedly plotting a Japanese rollout sometime …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: Takeda preps rollout of Novavax shot for next year — report; G20 targets 70% world vaccination rate by mid-2022

Nicole DeFeudis

Editor

Josh Sullivan

Sign up to read this article for free.

WuXi AppTec will sell cell and gene therapy business to private equity firm

The Endpoints 2024 winners and losers list: Who was up and who was down in biopharma

CagriSema’s weight loss data disappointed. What does Novo do next?

CMS explains what went into its first round of drug price negotiations

Vertex gets 'vanza triple' approval and Trikafta expansion — with boxed warnings

FDA approves Lilly's Zepbound for sleep apnea, likely cracking open Medicare market

Covid-19 roundup: Take­da preps roll­out of No­vavax shot for next year — re­port; G20 tar­gets 70% world vac­ci­na­tion rate by mid-2022

Editor

Sign up to read this article for free.

more like this

Covid-19 roundup: Takeda preps rollout of Novavax shot for next year — report; G20 targets 70% world vaccination rate by mid-2022